Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
|ClinicalTrials.gov Identifier: NCT00339963|
Recruitment Status : Completed
First Posted : June 21, 2006
Last Update Posted : April 5, 2018
National Cancer Institute (NCI)
Lymphoma/Leukemia Molecular Profiling Project (LLMPP)
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Primary Completion Date :||No date given|
|Study Completion Date :||No date given|
Gascoyne RD, Adomat SA, Krajewski S, Krajewska M, Horsman DE, Tolcher AW, O'Reilly SE, Hoskins P, Coldman AJ, Reed JC, Connors JM. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood. 1997 Jul 1;90(1):244-51.
Vose JM. Current approaches to the management of non-Hodgkin's lymphoma. Semin Oncol. 1998 Aug;25(4):483-91. Review.